ライフサイエンスコーパス: syncytial

1 p of cell division, and are a key feature of syncytial architectures in the germline of most metazoan

2 ces a protein gradient that functions in the syncytial blastoderm after 9-10 nuclear divisions.

3 s limited the sensitivity of analysis of pre-syncytial blastoderm embryos and precluded studies of oo

4 methods to analyze stage 14 oocytes and pre-syncytial blastoderm embryos, and found that stage 14 oo

5 In Drosophila, the cleavage of the syncytial blastoderm is initiated by an actomyosin netwo

6 series of rapid nuclear divisions before the syncytial blastoderm starts to cellularize.

7 orsal accumulates on the ventral side of the syncytial blastoderm.

8 e regulation of Cdk1 waves in the Drosophila syncytial blastoderm.

9 rent at nuclear cycle 7, two cycles prior to syncytial blastoderm.

10 actant identified pneumocytes and epithelial syncytial cells as important targets of MERS-CoV antigen

11 colocalization in scattered pneumocytes and syncytial cells.

12 ro of syncytiumlike structures that resemble syncytial cytomegalic cells that are associated with CMV

13 phila Pseudocleavage furrow membranes in the syncytial Drosophila blastoderm embryo show rapid extens

14 lized membrane cytoskeleton restraint in the syncytial Drosophila embryo.

15 Furrow formation in early syncytial Drosophila embryos is exceptionally rapid, wit

16 embryo cortex, maintain genome integrity in syncytial Drosophila embryos.

17 rapidly increasing numbers of nuclei in the syncytial embryo and for the spatially precise execution

18 ametes is mechanistically established in the syncytial embryo sac by spatially restricted CKI1 expres

19 segregation, and compartmentalization of the syncytial embryo.

20 t the base of plasma membrane furrows of the syncytial embryo.

21 tant for regular spatial organization of the syncytial embryo.

22 During interphase of syncytial embryos of Drosophila, cortical actin and the

23 ingle major Steppke-interacting protein from syncytial embryos, which we named Stepping stone (Sstn).

24 chromatin and reduced nuclear compaction in syncytial embryos.

25 dosperm enhances the number of nuclei during syncytial endosperm development and induces the partial

26 the short-lived placenta at the level of the syncytial feto-maternal interface; and it is conserved i

27 ore forming spores, with two species causing syncytial formation in the intestine and one species cau

28 ion in the intestine and one species causing syncytial formation in the muscle.

29 Multinucleate cellular syncytial formation is a hallmark of skeletal muscle dif

30 The machinery needed for syncytial formation is similar to that needed for direct

31 RalA localizes to syncytial furrows, and mediates the movement of exocytic

32 hereas the Caenorhabditiselegans germline is syncytial, its formation remains poorly understood.

33 ing attracted to their destination, the yolk syncytial layer, cells appear to migrate away from their

34 rlier experiments made use of only the A855V syncytial mutant of glycoprotein B (gB), and the Syn phe

35 of particular interest is the absence of gL syncytial mutants in other herpesviruses.

36 s not abolish the hyperfusogenic activity of syncytial mutations and that these mutations do not elim

37 assays, respectively, and we found that the syncytial mutations did not override the receptor specif

38 ell fusion, but only for mutants that harbor syncytial mutations in gB (not variants of gK, UL20, or

39 We introduced selected syncytial mutations into gB and/or gK of the EGFR-retarg

40 Here we introduced syncytial mutations into the gB and/or gK gene of gD-ret

41 These observations suggest that syncytial mutations may be valuable for increasing the t

42 Syncytial mutations, predominantly mapped to the gB and

43 r cell-to-cell spread even in the absence of syncytial mutations.

44 nion differentiate normally but fail to form syncytial myotubes, and Minion-deficient mice die perina

45 o distribute nuclei throughout the length of syncytial myotubes.

46 Placentas from AMA women exhibited increased syncytial nuclear aggregates and decreased proliferation

47 tension in processes such as cytokinesis and syncytial nuclear division cycles in Drosophila Pseudocl

48 monstrate that the cell-specific topology of syncytial nuclei is dependent on cell division.

49 ant, developing females and their associated syncytial nurse cells were significantly smaller than in

50 ll virus, and all produced lytic rather than syncytial sites of infection.

51 and fusion of the mononucleated state to the syncytial state are of major importance to a successful

52 ispensable for initiating membrane fusion of syncytial strains.

53 e null mutant resulted in rapid outgrowth of syncytial (Syn) variants.

54 At the syncytial tissue level, we discuss optogenetically enabl

55 Sequencing of the syncytial variants revealed mutations in the gK locus, b

56 espiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality",

57 er respiratory illness caused by respiratory syncytial virus (41.2% vs. 21.4%; P = 0.001); and physic

58 12.8%]), adenovirus (64 [6.0%]), respiratory syncytial virus (60 [5.6%]), and Streptococcus pneumonia

59 Respiratory syncytial virus (83%) and human rhinovirus (34%) were mo

60 Human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV)

61 The human respiratory syncytial virus (HRSV) core viral RNA polymerase compris

62 The human respiratory syncytial virus (hRSV) fusion (F) protein is considered

63 Human respiratory syncytial virus (hRSV) is a leading cause of acute lower

64 Human respiratory syncytial virus (hRSV) is a major cause of morbidity and

65 Human respiratory syncytial virus (HRSV) is a major cause of serious respi

66 Human respiratory syncytial virus (HRSV) is a major pediatric pathogen.

67 Human respiratory syncytial virus (hRSV) is responsible for serious lower

68 Human respiratory syncytial virus (hRSV) is the leading cause of severe lo

69 Human respiratory syncytial virus (HRSV) is the most important viral cause

70 Human respiratory syncytial virus (HRSV) represents a major health care an

71 Human respiratory syncytial virus (hRSV) vaccine development has received

72 r epidemiological study of human respiratory syncytial virus (HRSV) was conducted to examine the dist

73 ared with those induced by human respiratory syncytial virus (HRSV), a virus with a similar genome or

74 nce with pre-fusion F from human respiratory syncytial virus (hRSV), and collectively our results sho

75 animal pathogens, such as human respiratory syncytial virus (hRSV), hMPV, bovine RSV, and avian meta

76 animal pathogens, such as human respiratory syncytial virus (hRSV), hMPV, bovine RSV, and avian meta

77 For human respiratory syncytial virus (hRSV), VLP assembly is poorly understoo

78 study the closely related human respiratory syncytial virus (hRSV).

79 = 3.3; 95% CI, 1.5-7.1), but not respiratory syncytial virus (odds ratio = 1.0; 95% CI, 0.4-2.3), was

80 R4, TLR7/8-selective ligands, or respiratory syncytial virus (RSV) +/- 1,25(OH)2D3.

81 Human respiratory syncytial virus (RSV) A ON1 genotype, first detected in

82 the association of influenza and respiratory syncytial virus (RSV) activity with risk of pulmonary ex

83 Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) a

84 Human respiratory syncytial virus (RSV) and human parainfluenza virus type

85 Human respiratory syncytial virus (RSV) and human parainfluenza virus type

86 Respiratory syncytial virus (RSV) and human parainfluenza virus type

87 piratory paramyxoviruses such as respiratory syncytial virus (RSV) and human parainfluenza virus type

88 Respiratory syncytial virus (RSV) and human parainfluenza virus type

89 Respiratory syncytial virus (RSV) and human rhinovirus (HRV) are the

90 been recognized, with early-life respiratory syncytial virus (RSV) and rhinovirus (RV) lower respirat

91 Vaccines and antivirals against respiratory syncytial virus (RSV) are being developed, but there are

92 Infections with respiratory syncytial virus (RSV) are common and can cause severe lu

93 espiratory tract infections from respiratory syncytial virus (RSV) are due, in part, to secreted sign

94 prophylactic antibodies against respiratory syncytial virus (RSV) are in development and likely to b

95 Influenza A and B viruses and respiratory syncytial virus (RSV) are three common viruses implicate

96 Respiratory syncytial virus (RSV) belongs to the family Paramyxoviri

97 Respiratory syncytial virus (RSV) bronchiolitis in infancy is a majo

98 e lack of a licensed vaccine for respiratory syncytial virus (RSV) can be partly attributed to regula

99 Respiratory syncytial virus (RSV) causes acute lower respiratory tra

100 Respiratory syncytial virus (RSV) causes lower respiratory tract ill

101 Respiratory syncytial virus (RSV) causes severe respiratory tract in

102 on (post-F) conformations of the respiratory syncytial virus (RSV) F glycoprotein, is the only prophy

103 gated as a vector to express the respiratory syncytial virus (RSV) fusion (F) glycoprotein, to provid

104 oteins, F/F and H/G, composed of respiratory syncytial virus (RSV) fusion protein (F) and glycoprotei

105 d whether children with a higher respiratory syncytial virus (RSV) genomic load are at a higher risk

106 Data on how respiratory syncytial virus (RSV) genotypes influence disease severi

107 nited States, the seasonality of respiratory syncytial virus (RSV) has traditionally been defined on

108 The significant burden of Respiratory Syncytial Virus (RSV) in pediatric and elderly populatio

109 However, both respiratory syncytial virus (RSV) infection and mutations in the rec

110 ss this, we developed a model of respiratory syncytial virus (RSV) infection based on well-differenti

111 ade of immune events after acute respiratory syncytial virus (RSV) infection have been obtained from

112 mission of asymptomatic cases of respiratory syncytial virus (RSV) infection have not been well descr

113 ith Heligmosomoides polygyrus on respiratory syncytial virus (RSV) infection in a mouse model.

114 Respiratory syncytial virus (RSV) infection in infants has recogniza

115 Respiratory syncytial virus (RSV) infection induces asthma exacerbat

116 ral IFN signaling in response to respiratory syncytial virus (RSV) infection induces bacterial biofil

117 BACKGROUND Respiratory syncytial virus (RSV) infection is a cause of substantia

118 Respiratory syncytial virus (RSV) infection is a major cause of seve

119 Respiratory syncytial virus (RSV) infection is an important cause of

120 Respiratory syncytial virus (RSV) infection of children previously i

121 Children with acute respiratory syncytial virus (RSV) infection often develop sequelae o

122 l4) was upregulated on APC after respiratory syncytial virus (RSV) infection, and its inhibition lead

123 Here, using experimental human respiratory syncytial virus (RSV) infection, we investigate systemic

124 a murine CB6F1/J hybrid model of respiratory syncytial virus (RSV) infection, we previously demonstra

125 mmatory cytokines in response to respiratory syncytial virus (RSV) infection.

126 Respiratory syncytial virus (RSV) infections remain a major cause of

127 antivirals for the treatment of respiratory syncytial virus (RSV) infections.

128 Respiratory syncytial virus (RSV) infects epithelial cells of the re

129 Human respiratory syncytial virus (RSV) is a common cause of severe respir

130 Human respiratory syncytial virus (RSV) is a frequent cause of asthma exac

131 vaccine antigen.IMPORTANCE Human respiratory syncytial virus (RSV) is a global leading cause of infan

132 Respiratory syncytial virus (RSV) is a global respiratory pathogen o

133 Respiratory syncytial virus (RSV) is a highly contagious pathogen wi

134 Respiratory syncytial virus (RSV) is a leading cause of childhood br

135 Respiratory syncytial virus (RSV) is a leading cause of infant hospi

136 Respiratory syncytial virus (RSV) is a leading cause of infant morbi

137 Respiratory syncytial virus (RSV) is a leading cause of lower respir

138 Respiratory syncytial virus (RSV) is a leading cause of lower respir

139 Respiratory syncytial virus (RSV) is a leading cause of respiratory

140 Respiratory syncytial virus (RSV) is a leading pathogen of childhood

141 Human respiratory syncytial virus (RSV) is a major cause of morbidity and

142 Respiratory syncytial virus (RSV) is a major cause of respiratory in

143 Respiratory syncytial virus (RSV) is a major cause of upper and lowe

144 Respiratory syncytial virus (RSV) is a major health care burden with

145 Respiratory syncytial virus (RSV) is a major worldwide cause of morb

146 Respiratory syncytial virus (RSV) is a primary etiological agent of

147 Human respiratory syncytial virus (RSV) is a single-stranded RNA virus tha

148 Respiratory syncytial virus (RSV) is an exceptional mucosal pathogen

149 Respiratory syncytial virus (RSV) is an important cause of illness i

150 Human respiratory syncytial virus (RSV) is an important pathogen causing a

151 Respiratory syncytial virus (RSV) is an important pathogen for infan

152 Human respiratory syncytial virus (RSV) is associated with severe childhoo

153 Respiratory syncytial virus (RSV) is increasingly recognized as a si

154 The Human respiratory syncytial virus (RSV) is one of the most important viral

155 Respiratory Syncytial Virus (RSV) is responsible for considerable mo

156 spite decades of research, human respiratory syncytial virus (RSV) is still a major health concern fo

157 Respiratory syncytial virus (RSV) is the leading cause of acute lowe

158 Infection with the respiratory syncytial virus (RSV) is the leading cause of hospitaliz

159 Although respiratory syncytial virus (RSV) is the leading cause of lower resp

160 Respiratory syncytial virus (RSV) is the leading cause of lower resp

161 Human respiratory syncytial virus (RSV) is the leading cause of lower resp

162 Human respiratory syncytial virus (RSV) is the leading cause of pediatric

163 Respiratory syncytial virus (RSV) is the leading cause of pediatric

164 Human respiratory syncytial virus (RSV) is the leading etiologic agent of

165 Respiratory syncytial virus (RSV) is the main causative agent of bro

166 Human respiratory syncytial virus (RSV) is the main cause of lower respira

167 Respiratory syncytial virus (RSV) is the major cause of lower respir

168 Respiratory syncytial virus (RSV) is the most common cause of seriou

169 Respiratory syncytial virus (RSV) is the most common cause of US inf

170 Respiratory syncytial virus (RSV) is the most common cause of viral

171 RATIONALE: Respiratory syncytial virus (RSV) is the most frequent cause of hosp

172 Human respiratory syncytial virus (RSV) is the most frequent cause of infa

173 Respiratory syncytial virus (RSV) is the most frequent cause of lowe

174 Human respiratory syncytial virus (RSV) is the most important lower respir

175 Respiratory syncytial virus (RSV) is the most important viral agent

176 Respiratory syncytial virus (RSV) is the most important viral cause

177 Respiratory syncytial virus (RSV) is the most important viral pathog

178 Human respiratory syncytial virus (RSV) is the most prevalent worldwide ca

179 A licensed vaccine for respiratory syncytial virus (RSV) is unavailable, and passive prophy

180 Respiratory syncytial virus (RSV) lower respiratory tract infection

181 Passively acquired respiratory syncytial virus (RSV) neutralizing antibody protects aga

182 Viral etiology was defined as respiratory syncytial virus (RSV) or rhinovirus (RV), including coin

183 es, the role of this receptor in respiratory syncytial virus (RSV) pathogenesis is controversial.

184 CRP for identifying bacterial vs respiratory syncytial virus (RSV) pneumonia in the Pneumonia Etiolog

185 Respiratory syncytial virus (RSV) remains a major human pathogen, in

186 The infant immune response to respiratory syncytial virus (RSV) remains incompletely understood.

187 f bacterial infections following respiratory syncytial virus (RSV) remains unclear.

188 ith enhanced rhinovirus (RV) and respiratory syncytial virus (RSV) replication.

189 two mouse OASL homologs against respiratory syncytial virus (RSV) replication.

190 Respiratory syncytial virus (RSV) represents a threat to infants, th

191 The study was conducted during respiratory syncytial virus (RSV) seasons, before pneumococcal vacci

192 e is no licensed vaccine against respiratory syncytial virus (RSV) since the failure of formalin-inac

193 way to develop a vaccine against respiratory syncytial virus (RSV) that will provide protective immun

194 tory tract illness (LRTI) due to respiratory syncytial virus (RSV) to inform selection of clinical en

195 nically meaningful endpoints for respiratory syncytial virus (RSV) treatment trials are lacking for h

196 c reversion of deoptimized human respiratory syncytial virus (RSV) vaccine candidates in the context

197 MPORTANCE A safe and efficacious respiratory syncytial virus (RSV) vaccine remains elusive.

198 All live attenuated respiratory syncytial virus (RSV) vaccines that have advanced to cli

199 e have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all epi

200 or influenza A and B viruses and respiratory syncytial virus (RSV) was compared to a centralized labo

201 tic recurrent epidemics of human respiratory syncytial virus (RSV) within communities may result from

202 y all children are infected with respiratory syncytial virus (RSV) within the first 2 years of life,

203 There are two subgroups of respiratory syncytial virus (RSV), A and B, and within each subgroup

204 The latter includes respiratory syncytial virus (RSV), a human pathogen that can cause s

205 fective and safe vaccine against respiratory syncytial virus (RSV), a leading cause of respiratory di

206 e small hydrophobic (SH) gene of respiratory syncytial virus (RSV), a major cause of infant hospitali

207 ts for influenza viruses, 32 for respiratory syncytial virus (RSV), and 13 for other respiratory viru

208 r viral infections, such as HIV, respiratory syncytial virus (RSV), and influenza, are increasingly e

209 us (HSV), human papilloma virus, respiratory syncytial virus (RSV), dengue and lenti virus.

210 y childhood, including that from respiratory syncytial virus (RSV), has been previously associated wi

211 nd serology for the diagnosis of respiratory syncytial virus (RSV), human metapneumovirus (HMPV), par

212 of three common paramyxoviruses, Respiratory Syncytial Virus (RSV), Human Parainfluenza Virus (HPIV),

213 age and female sex; detection of respiratory syncytial virus (RSV), influenza, rhinovirus, metapneumo

214 ial cells are the main target of respiratory syncytial virus (RSV), it also infects immune cells, suc

215 During infection with respiratory syncytial virus (RSV), STAT1-deficient mice had reduced

216 cular Stomatitis Virus (VSV) and Respiratory Syncytial Virus (RSV), without cytotoxicity.

217 322 HIV-uninfected children with respiratory syncytial virus (RSV)-associated LRTI, 1330 (57.3%) had

218 The high burden of respiratory syncytial virus (RSV)-associated morbidity and mortality

219 we established a mouse model of respiratory syncytial virus (RSV)-induced exacerbation after allerge

220 hiolitis were recruited: 12 were respiratory syncytial virus (RSV)-positive, 12 were RSV-negative.

221 We studied preexisting respiratory syncytial virus (RSV)-specific serum and nasal antibodie

222 h a system to study and forecast respiratory syncytial virus (RSV).

223 the Paramyxoviridae family with Respiratory Syncytial Virus (RSV).

224 sk for severe disease because of respiratory syncytial virus (RSV).

225 pressing need for a vaccine for respiratory syncytial virus (RSV).

226 similar to an antigenic site on respiratory syncytial virus (RSV).

227 spitalization rates for HMPV and respiratory syncytial virus (RSV).

228 irus (HRV), influenza virus, and respiratory syncytial virus (RSV).

229 uman rhinovirus (HRV; n = 52) or respiratory syncytial virus (RSV; n = 83).

230 c in patients at risk to develop respiratory syncytial virus acute lower respiratory tract infection.

231 ual viruses including influenza, respiratory syncytial virus and dengue, but the generality of these

232 athogens Pseudomonas aeruginosa, respiratory syncytial virus and influenza viruses, with particular f

233 n appears to be within reach for respiratory syncytial virus and promising for influenza virus, where

234 y restricts replication of human respiratory syncytial virus and rhinoviruses.

235 odels of 2 childhood infections (respiratory syncytial virus and rotavirus) to illustrate this proble

236 and tuberculosis, as well as for respiratory syncytial virus and those chronic and debilitating (most

237 Respiratory syncytial virus antigens were detected in circulating CD

238 Group B streptococcus and respiratory syncytial virus are leading causes of infant morbidity a

239 ively, our results show that for respiratory syncytial virus assembly, viral filaments are produced a

240 Respiratory syncytial virus caused 66% of the bronchiolitis cases, a

241 ower respiratory tract infection.Respiratory syncytial virus causes lung infections in children, immu

242 Severe respiratory syncytial virus disease can be prevented by passively ad

243 duced prevalence and severity of respiratory syncytial virus disease in the first few weeks of life,

244 rves as a model for severe human respiratory syncytial virus disease.

245 sequence of an unpassaged human respiratory syncytial virus from a sample obtained directly from an

246 ructure of JNJ-53718678 bound to respiratory syncytial virus fusion (F) protein in its prefusion conf

247 g mode of JNJ-53718678 and other respiratory syncytial virus fusion inhibitors.

248 lutinin to selectively label the respiratory syncytial virus G protein in living cells without disrup

249 The human respiratory syncytial virus G protein plays an important role in the

250 vered that plasma membrane-bound respiratory syncytial virus G rapidly recycles from the membrane via

251 t mortality risk, and those with respiratory syncytial virus had the lowest.

252 delayed until external signs of respiratory syncytial virus illness have become visible.

253 identified in 91.9% of patients (respiratory syncytial virus in 51.4%, human rhinovirus in 11.7%).

254 fidence interval [CI], 1.4-3.9), respiratory syncytial virus infection (aRR, 1.9; 95% CI, 1.3-3.0) an

255 Respiratory syncytial virus infection induced strong and persistent

256 we report that during Sendai and respiratory syncytial virus infections DVGs selectively protect a su

257 revent group B streptococcus and respiratory syncytial virus infections, among others.

258 living cells without disrupting respiratory syncytial virus infectivity or filament formation and al

259 Respiratory syncytial virus infects CD4+ and CD8+ T cells and compro

260 Respiratory syncytial virus is a major cause of acute lower respirat

261 aternal IgG antibody specific to respiratory syncytial virus is associated with reduced prevalence an

262 binding sites recognized by the respiratory syncytial virus nucleoprotein and compatible with weak i

263 tion of filamentous and branched respiratory syncytial virus particles, and assembly with genomic rib

264 molecule antivirals specific for respiratory syncytial virus presents an important therapeutic opport

265 n-competent IAV-WSN strain and a respiratory syncytial virus reporter strain for the simultaneous ide

266 hilus influenzae, influenza, and respiratory syncytial virus respiratory tract infections and ovalbum

267 tension assays using a surrogate respiratory syncytial virus RNA polymerase.

268 d allowing for interrogations of respiratory syncytial virus virion assembly.

269 A high genomic load of respiratory syncytial virus was associated with a longer length of s

270 or increased mortality risk, and respiratory syncytial virus was associated with lowest mortality ris

271 015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combi

272 Detections of influenza, respiratory syncytial virus, and human metapneumovirus among patient

273 Detections of influenza, respiratory syncytial virus, and human metapneumovirus were substant

274 ditions, with influenza viruses, respiratory syncytial virus, and rhinoviruses being the most frequen

275 easles virus, mumps virus, human respiratory syncytial virus, and the zoonotic paramyxoviruses Nipah

276 enterovirus 71, influenza virus, respiratory syncytial virus, dengue virus, and Ebola virus, among ot

277 uses, including influenza virus, respiratory syncytial virus, human immunodeficiency virus, human T c

278 ps virus, parainfluenza viruses, respiratory syncytial virus, human metapneumovirus, and the deadly z

279 gainst group B streptococcus and respiratory syncytial virus, identifies knowledge gaps regarding the

280 iruses, such as rhinoviruses and respiratory syncytial virus, in asthma development.

281 ly challenged with either bovine respiratory syncytial virus, infectious bovine rhinotracheitis, bovi

282 ssa virus), and Paramyxoviridae (respiratory syncytial virus, Nipah virus) to suppress infectious vir

283 itis C virus, influenza A virus, respiratory syncytial virus, Nipah virus, Lassa virus, and Ebola vir

284 her respiratory pathogens: human respiratory syncytial virus, parainfluenza virus 5, and Sendai virus

285 ex polymerase chain reaction for respiratory syncytial virus, parainfluenza viruses 1-4, influenza A

286 oviruses, human metapneumovirus, respiratory syncytial virus, parainfluenza viruses, and Haemophilus

287 y viruses (NIRVs), which include respiratory syncytial virus, parainfluenza viruses, coronavirus, rhi

288 itiatives-group B streptococcus, respiratory syncytial virus, pertussis, and influenza.

289 Nine respiratory virus types (respiratory syncytial virus, rhinoviruses, other picornaviruses, cor

290 dies on tuberculosis, influenza, respiratory syncytial virus, SARS-Coronavirus and pneumonia.

291 s including, asthma, aspiration, respiratory syncytial virus, sepsis-induced respiratory failure, per

292 used to investigate a nosocomial respiratory syncytial virus-B (RSV-B) outbreak in a hematology-oncol

293 Respiratory syncytial virus-bronchiolitis is a major independent ris

294 Finally, influenza- and respiratory syncytial virus-induced CXCL-10 was also found to be par

295 In contrast, reduced respiratory syncytial virus-induced IL-8 responses and increased 5'-

296 80% of the phosphoprotein of the respiratory syncytial virus.

297 rabies virus, measles virus, and respiratory syncytial virus.

298 pic asthma were the first severe respiratory syncytial virus/rhinovirus-negative wheezing episode (ad

299 cular analyses showed that human respiratory syncytial viruses (HRSV) and human metapneumoviruses (HM

300 oviruses (EVs), influenza virus, respiratory syncytial viruses (RSVs), and coronaviruses are highly p